$0.29
+0.01 (+2.38%)
Open$0.29
Previous Close$0.29
Day High$0.31
Day Low$0.28
52W High$17.17
52W Low$0.27
Volume—
Avg Volume99.9K
Market Cap53.90M
P/E Ratio—
EPS$-0.28
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 611.77M | 804.64M | 106.35M |
| Net Income | -35,176,084 | -41,639,452 | 12.42M |
| Profit Margin | -5.8% | -5.5% | 11.7% |
| EBITDA | 18.62M | 23.26M | 22.69M |
| Free Cash Flow | — | — | 8.29M |
| Rev Growth | -24.0% | -24.0% | +7.5% |
| Debt/Equity | — | — | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |